Results 251 to 260 of about 11,112,016 (340)
Generative artificial intelligence (AI) is increasingly being used in rheumatology practice, to assist with tasks such as documentation, record summarization, and clinical decision support. Rheumatologists need a practical approach to determining what evidence and oversight each application requires.
Koushan Kouranloo +2 more
wiley +1 more source
Estimating the Direct Medical Costs of Smoking-Attributable Non-communicable Diseases in Northeastern Iran From 2015 to 2023. [PDF]
Abbasi A +6 more
europepmc +1 more source
Objective This study synthesized the content and reporting completeness of published physical therapist–led interventions for glenohumeral osteoarthritis (GHOA). Methods This systematic review undertook electronic database searches in PubMed, EMBASE, Cochrane, CINAHL, and PEDro (until June 2025) for any peer‐reviewed articles or studies describing ...
Daha G. Muhammad +5 more
wiley +1 more source
Annual direct medical costs of bronchiectasis treatment
D. de la Rosa +5 more
semanticscholar +1 more source
The Direct Medical Costs of Sickle Cell Disease in Saudi Arabia: Insights from a Single Center Study. [PDF]
AlRuthia Y.
europepmc +1 more source
A thermoplastic PMMA‐based photoresin enables high‐resolution DLP printing followed by solvent‐vapor smoothing. The treatment reduces staircase‐induced surface roughness from 2.33 µm to 129 nm and increases visible‐light transmittance from approximately 30% to 80%, providing a route toward transparent PMMA components for rapid prototyping and non ...
Rozhin Heydarpour +5 more
wiley +1 more source
Direct medical costs of cardiovascular diseases: Do cost components vary according to sex and age? [PDF]
Gilbert-Ouimet M +8 more
europepmc +1 more source
ABSTRACT Chitosan, a polysaccharide upcycled from biowaste, has long promised sustainable, biocompatible, and antimicrobial films and devices, an appeal reinforced by its recent regulatory recognition, with several chitosan‐based antibacterial dressings gaining clearance through the Food and Drug Administration's 510(k) pathway.
Jacopo Nicoletti +16 more
wiley +1 more source

